EPM speaks to Rami Cassis, executive chairman of pharmaceutical serialisation company Advanco and CEO of Parabellum Investments about the rise in counterfeit medicines during the Covid-19 pandemic.
Dr Peter Jackson, executive director of the AMR Centre explains why a new clinical trial taking place in the UK could represent a major step forward in the fight against antimicrobial resistance (AMR).
Maurits Lugard, Dr. Dorothee Schramm, and Anna-Shari Melin from law firm Sidley & Austin explain how pharmaceutical companies with products on the EU market can address product shortages and supply chain issues in the current Covid-19 crisis.
As the Covid-19 pandemic continues, pharmaceutical companies are taking generous steps and removing intellectual property rights for many key drugs which could help fight the virus.
With countries around the world beginning to consider steps to ease their lockdown restrictions now may be the best time to look at the lessons we should have learned from the Covid-19 crisis.
The generics industry is a crucial partner in the fight against Covid-19 where cross-industry partnerships and alliances are creating a new normal, writes Tony Cordrey, VP Operations, Accord Healthcare EMENA.
Noel Maestre, advanced therapy medicinal product (ATMP) director at CRB guides readers through the steps needed to implement manufacturing strategies for advanced medicines.
EPM speaks to Neil Tween, CFO at Owlstone Medical, who tells us why diagnostics still have a vital role to play in healthcare and the lessons he's learned from working in the industry.
